Loading
Pradaxa • Direct oral anticoagulant (Direct thrombin inhibitor) • Kidney function: 30–44 mL/min/1.73m² (or CrCl 30–50)
The recommended dose of Dabigatran (Pradaxa) and Kidneys at 30–44 mL/min/1.73m² (or CrCl 30–50) — with monitoring notes for kidney disease and dialysis.
150 mg twice daily (or 110 mg BID with bleeding risk factors).
CrCl 30-50: 150 mg BID; lower dose often chosen in the elderly with additional bleeding risk.
Doses in this guide follow drug labels and renal-dosing references at each eGFR/CrCl level. Always confirm with your prescriber and pharmacy — your specific dose depends on other medications, conditions, and lab results.
Full Dabigatran (Pradaxa) and Kidneys kidney guideDabigatran (Pradaxa) and Kidneys has its own monitoring requirements (eGFR, potassium, drug levels, or blood counts). These become more frequent as kidney function falls. Report unusual weakness, irregular heartbeat, or new side effects promptly.
Interactive drug-dosing tool